MARKET

RKDA

RKDA

Arcadia
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.610
+0.130
+5.24%
After Hours: 2.690 +0.08 +3.07% 17:49 05/17 EDT
OPEN
2.480
PREV CLOSE
2.480
HIGH
2.650
LOW
2.470
VOLUME
1.62M
TURNOVER
--
52 WEEK HIGH
6.40
52 WEEK LOW
2.260
MARKET CAP
55.69M
P/E (TTM)
-4.7969
1D
5D
1M
3M
1Y
5Y
BRIEF-Arcadia Biosciences Inc Posts Quarterly EPS Of $0.11
reuters.com · 57m ago
BRIEF-Arcadia Biosciences Acquires Lief Brands
reuters.com · 1h ago
Arcadia Biosciences acquires Lief brands
Arcadia Biosciences (RKDA) announced the acquisition of assets of Lief Holdings, LLC and its product portfolio from The Parent Company along with select assets of Live Zola, LLC.The deal for assets
Seekingalpha · 1h ago
Arcadia Biosciences EPS beats by $0.45, beats on revenue
Arcadia Biosciences (RKDA): Q1 GAAP EPS of $0.11 beats by $0.45.Revenue of $0.83M (+167.7% Y/Y) beats by $0.1M.Shares +12.3%.Press Release
Seekingalpha · 1h ago
Arcadia Biosciences, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 17, 2021 / Arcadia Biosciences, Inc. (NASDAQ:RKDA) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 17, 2021 at 4:30 PM Eastern Time.
ACCESSWIRE · 3h ago
Arcadia Biosciences' EPS Declines as Revenue Jumps; Acquires Assets of Lief Holdings; Shares Jump After-Hours
MT Newswires · 5h ago
-- Earnings Flash (RKDA) ARCADIA BIOSCIENCES Posts Q1 Revenue $828,000
MT Newswires · 5h ago
Earnings Reaction History: Arcadia Biosciences Inc, 40.0% Follow-Through Indicator, 11.6% Sensitive
MT Newswires · 9h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RKDA. Analyze the recent business situations of Arcadia through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RKDA stock price target is 6.45 with a high estimate of 6.89 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 33
Institutional Holdings: 1.52M
% Owned: 7.11%
Shares Outstanding: 21.34M
TypeInstitutionsShares
Increased
7
198.14K
New
3
109.05K
Decreased
1
2.60K
Sold Out
1
128.04K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Agricultural Chemicals
+0.19%
Chemicals
+0.26%
Key Executives
Chairman/Director
Kevin Comcowich
Chief Executive Officer/Director
Matthew Plavan
Chief Financial Officer
Pam Haley
Chief Financial Officer
Pamela Haley
Vice President - Operations
Belinda Yao
Vice President
Tracy Baker
Vice President
Donald Emlay
Vice President
Kevin Hodges
Other
Zhongjin Lu
Other
Sarah Reiter
Director
Jamie Bechtel
Director
Albert Bolles
Director
Debbie Carosella
Director
Peter Gajdos
Director
Lilian Shackleford Murray
Director
Gregory Waller
Director
Amy Yoder
No Data
About RKDA
Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The Company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency (NUE), Water Use Efficiency (WUE), Drought Tolerance (DT), Salinity Tolerance (ST) and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.

Webull offers kinds of Arcadia Biosciences Inc stock information, including NASDAQ:RKDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RKDA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RKDA stock methods without spending real money on the virtual paper trading platform.